Overview
A technology for amplifying nucleic acids (DNA/RNA) of genes or pathogens, or directly diagnosing specific diseases.It enables rapid detection and analysis of infectious diseases (such as COVID-19, tuberculosis, hepatitis, HIV, and influenza), cancers (including lung, breast, and colorectal cancers with specific mutations), Alzheimer’s disease, and genetic disorders.
RevoSketch successfully launched “digiQuark” in July 2024 a next-generation digital PCR platform featuring high-sensitivity and high-accuracy early diagnostics through automated partitioning using centrifugal force and real-time screening, a core technology in the future of precision medicine.In addition, our Isothermal PCR system, “isoQuark”, has been selected as an innovative procurement product and is currently being supplied to domestic and international partners across academia, industry, research institutes, and medical centers.